Skip to main content
Chi-Yuan Hsu, MD, Nephrology, San Francisco, CA

Chi-YuanHsuMDMSc

Nephrology San Francisco, CA

Professor, Chief of the Division of Nephrology, University of California, San Francisco

Dr. Hsu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hsu's full profile

Already have an account?

  • Office

    513 Parnassus Ave
    # 0532
    San Francisco, CA 94143
    Phone+1 415-476-2172
    Fax+1 415-476-3381

Summary

  • Dr. Chi-Yuan Hsu is a nephrologist in San Francisco, CA and is affiliated with UCSF Medical Center. He received his medical degree from Harvard Medical School and has been in practice 24 years. He also speaks multiple languages, including Chinese (Cantonese) and Chinese (Mandarin). He is experienced in acute renal failure and chronic kidney disease.

Education & Training

  • Harvard School of Public Health
    Harvard School of Public HealthM.Sc., Clinical Epidemiology, 1999
  • Brigham and Women's Hospital/Massachusetts General Hospital
    Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1996 - 1998
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1996
  • Harvard Medical School
    Harvard Medical SchoolClass of 1993
  • Yale College
    Yale CollegeB.S./.M.S., Molecular Biophysics & Biochemistry, Summa Cum Laude, 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2027
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Satellite Healthcare “Overall” ICARE award to Wellbound San Francisco dialysis unit 2015
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Nominated for the 2012 Department of Epidemiology and Biostatistics Training in Clinical Research (TICR) Advising Award UCSF, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Implication of Trends in Timing of Dialysis Initiation for Incidence of End-Stage Kidney Disease  
    Chi-Yuan Hsu, Leonid N Pravoverov, Alan S Go, JAMA Internal Medicine
  • Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial  
    Daniel E Weiner, Meyeon Park, Alin A Joseph, Nitender Goyal, Chi-Yuan Hsu, Clifton E Kew, Todd E Pesavento, Andrew S Levey, American Journal of Kidney Diseases
  • Biological Variability of Estimated GFR and Albuminuria in CKD  
    Sushrut S Waikar, Chi-Yuan Hsu, Harold I Feldman, Kathleen D Liu, Joseph V Bonventre, Lesley A Inker, American Journal of Kidney Diseases
  • Join now to see all

Books/Book Chapters

Lectures

  • Diabetes and Advanced CKD: Diabetologists and Nephrologists on the Frontline--ASN/ADA Joint Session 
    Philadelphia, PA - 1/1/2014
  • Toward Building Better Biomarkers Statistical Methodology 
    Bethesda, MD - 1/1/2014
  • Novel Biomarkers of Kidney Disease 
    Atlanta, GA - 1/1/2013
  • Join now to see all

Other

  • Biomarkers in chronic kidney disease 
    Bansal N, Hsu CY, ASN Kidney News
    1/1/2014
  • Mini-Sentinel Validation of Acute Kidney Injury Cases 
    Patel UD, Hardy NC, Smith DH, Gurwitz JH, Hsu CY, Parikh CR, Brunelli SM, Baker M, Forrow S, Comins C, Boudreau DM, Liu C, Pawloski PA, Selvam N, Selvan MS, Stratton S...
    www.minisentinel.org/methods/outcome_validation
    1/1/2013

Authored Content

  • Biological Variability of Estimated GFR and Albuminuria in CKDJuly 2018
  • Impact of a Primary Care CKD Registry in a US Public Safety-Net Health Care Delivery System: A Pragmatic Randomized TrialApril 2018

Other Languages

  • Chinese (Cantonese), Chinese (Mandarin)